Old Web
English
Sign In
Acemap
>
authorDetail
>
S. De Buck
S. De Buck
Novartis
Medicine
Pharmacology
Immune complex formation
Gastroenterology
Autoantibody
3
Papers
49
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
OP0250 A randomised, double-blind study to assess the safety, tolerability and preliminary efficacy of leniolisib (CDZ173) in patients with primary sjÖgren’s syndrome
2018
Annals of the Rheumatic Diseases
Thomas Dörner
Margit Zeher
U. Laessing
F. Chaperon
S. De Buck
A. Hasselberg
Marie-Anne Valentin
S. Ma
Maciej Cabanski
Christoph Kalis
Christoph Burkhart
Peter Gergely
Show All
Source
Cite
Save
Citations (14)
Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery
2016
Pharmaceutical Research
N. Gobeau
R. Stringer
S. De Buck
T. Tuntland
Bernard Faller
Show All
Source
Cite
Save
Citations (27)
Population PK‐PD Model for Tolerance Evaluation to the p38 MAP Kinase Inhibitor BCT197
2015
S. De Buck
W Hueber
A Vitaliti
F Straube
C Emotte
Gerard Bruin
Ralph Woessner
Show All
Source
Cite
Save
Citations (8)
1